DENVER, CO - August 19, 2025 - Denver Regenerative Medicine, a leader in non-surgical pain management solutions, announces a strategic partnership with a prominent Denver research institution to conduct clinical trials on advanced stem cell therapies for arthritis. This collaboration aims to further validate the clinic's pioneering dual-source stem cell approach that has shown remarkable success in treating patients with severe joint degeneration.
"This partnership represents a significant step forward in our mission to advance regenerative medicine and provide evidence-based alternatives to invasive surgeries," said Dr. Joel Cherdack, Medical Director at Denver Regenerative Medicine. "By combining our clinical expertise with rigorous scientific research, we aim to refine our protocols and improve outcomes for patients suffering from debilitating arthritis."
The clinical trial will focus on the clinic's innovative approach that utilizes both bone marrow-derived mesenchymal stem cells (MSCs) and adipose-derived stem cells. Denver Regenerative Medicine has been implementing this dual-source method since 2014, after observing that patients treated with both types of stem cells experienced approximately 30% faster recovery and more substantial tissue repair compared to those receiving single-source treatments.
Denver Regenerative Medicine has been at the forefront of stem cell therapy since 2012, initially using bone marrow-derived MSCs along with platelet-rich plasma (PRP) to treat joint, muscle, tendon, and bone injuries. The clinic later expanded its approach to include adipose-derived stem cells, which offer higher concentrations of regenerative cells and show particular effectiveness in promoting soft tissue healing.
"Our clinical observations over the past decade have consistently shown that combining both sources of stem cells creates a synergistic effect," Dr. Cherdack explained. "Bone marrow-derived cells excel at cartilage and bone regeneration, while adipose-derived cells provide abundant growth factors and support for soft tissue repair. Together, they address multiple aspects of joint degeneration simultaneously."
The formal clinical trial will track outcomes for patients with moderate to severe osteoarthritis who receive the combined stem cell treatment. Researchers will monitor pain levels, functional improvement, and structural changes in the affected joints over a two-year period. The study will include advanced imaging techniques to document tissue regeneration and comprehensive quality of life assessments.
This research initiative aligns with Denver Regenerative Medicine's commitment to physical medicine and rehabilitation approaches that minimize the need for pain medication and invasive procedures. The clinic has established itself as a respected pain management center in Colorado, offering evidence-based interventions for acute and chronic pain conditions.
The clinic's specialists in Denver, CO, have successfully treated thousands of patients with arthritis and related conditions using autologous (patient-derived) stem cells. Many patients who were candidates for joint replacement have maintained their natural joints for years following treatment, significantly improving their quality of life while avoiding major surgery.
For more information, please contact Dr. Joel Cherdack at https://denverregenerativemedicine.com/.
About Denver Regenerative Medicine
Denver Regenerative Medicine is a specialized clinic dedicated to providing innovative, non-surgical solutions for patients suffering from joint pain, arthritis, and sports injuries. Founded in 2012, the clinic offers comprehensive pain management services utilizing cutting-edge regenerative techniques, including stem cell therapy, platelet-rich plasma treatments, and targeted rehabilitation programs. The medical team combines expertise in pain management, orthopedics, and regenerative medicine to deliver personalized care plans that harness the body's natural healing abilities. Located in the heart of Denver at 455 Sherman St, Suite 450, the clinic serves patients throughout Colorado seeking alternatives to surgery and conventional pain management techniques.
Contact Information:
Dr. Joel Cherdack
Medical Director
Denver Regenerative Medicine
720-583-1648
455 Sherman St, Suite 450
Denver, CO 80203
https://denverregenerativemedicine.com/
Media Contact
Company Name: Denver Regenerative Medicine
Contact Person: Dr. Joel Cherdack
Email: Send Email
Phone: 720-583-1648
Address:455 Sherman St Suite 450
City: Denver
State: CO
Country: United States
Website: https://denverregenerativemedicine.com/